Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:advantage |
high specificity
good tissue penetration rapid renal clearance small molecular size |
| gptkbp:appliesTo |
oncology
immuno-oncology other disease areas |
| gptkbp:basedOn |
phage display
|
| gptkbp:commercialUse |
gptkb:Bicycle_Therapeutics
|
| gptkbp:developedBy |
gptkb:Bicycle_Therapeutics
|
| gptkbp:enables |
high affinity binding to targets
identification of constrained bicyclic peptides targeted delivery of drugs |
| https://www.w3.org/2000/01/rdf-schema#label |
Bicycle peptide technology
|
| gptkbp:produces |
bicyclic peptides
|
| gptkbp:relatedTo |
peptide therapeutics
constrained peptides macrocyclic peptides |
| gptkbp:usedFor |
drug discovery
therapeutics development |
| gptkbp:bfsParent |
gptkb:Bicycle_tumor-targeted_immune_cell_agonists_(Bicycle_TICAs)
|
| gptkbp:bfsLayer |
7
|